v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net loss $ (79,176) $ (68,710)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, depletion and amortization 52,150 38,762
Deferred income taxes (4,211) 437
Provision for credit losses 901 335
Amortization of debt issuance costs 979 787
Employee stock-based compensation costs 2,859 2,799
Pension and postretirement benefit plan net periodic benefit cost 464 360
Unrealized losses on investments 760 692
Gains on sales of assets (1,981) (2,410)
Gain on bargain purchase 0 (3,547)
Equity in (losses) earnings of unconsolidated affiliates (165) 15
Changes in current assets and liabilities, net of acquisitions:    
Receivables 52,549 41,081
Inventories (41,095) (50,360)
Other current assets (33,469) (35,473)
Accounts payable (5,285) (12,772)
Other current liabilities (8,455) (40,255)
Pension and postretirement benefit plan contributions (137) (158)
Other noncurrent changes 4,762 3,140
Net cash used in operating activities (58,550) (125,277)
Investing activities:    
Capital expenditures (77,316) (74,958)
Acquisitions, net of cash acquired (174,228) (443,439)
Net proceeds from sale or disposition of property and other 3,101 17,524
Investments (2,612) (2,760)
Net cash used in investing activities (251,055) (503,633)
Financing activities:    
Issuance of long-term debt 270,000 500,000
Repayment of long-term debt (2,930) (19)
Debt issuance costs 0 (11,070)
Tax withholding on stock-based compensation (5,425) (2,653)
Net cash provided by financing activities 261,645 486,258
Decrease in cash, cash equivalents and restricted cash (47,960) (142,652)
Cash, cash equivalents and restricted cash -- beginning of year 123,418 281,134
Cash, cash equivalents and restricted cash -- end of period $ 75,458 $ 138,482